SOX17 and pulmonary arterial hypertension: To test effects most relevant to the common and rare SOX17 variants associated with PAH, we generated SOX17 hPAEC signatures comprised of differentially expressed genes following CRISPR-inhibition of SOX17-signal 1 or the SOX17 promoter, or CRISPR-activation of the SOX17 promoter.